RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/24434213http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/24434213http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/24434213http://www.w3.org/2000/01/rdf-schema#comment"Current antiangiogenic therapy is limited by its cytostatic nature and systemic side effects. To address these limitations, we have unveiled the role of RhoJ, an endothelial-enriched Rho GTPase, during tumor progression. RhoJ blockade provides a double assault on tumor vessels by both inhibiting tumor angiogenesis and disrupting the preformed tumor vessels through the activation of the RhoA-ROCK (Rho kinase) signaling pathway in tumor endothelial cells, consequently resulting in a functional failure of tumor vasculatures. Moreover, enhanced anticancer effects were observed when RhoJ blockade was employed in concert with a cytotoxic chemotherapeutic agent, angiogenesis-inhibiting agent, or vascular-disrupting agent. These results identify RhoJ blockade as a selective and effective therapeutic strategy for targeting tumor vasculature with minimal side effects."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.org/dc/terms/identifier"doi:10.1016/j.ccr.2013.12.010"xsd:string
http://purl.uniprot.org/citations/24434213http://purl.org/dc/terms/identifier"doi:10.1016/j.ccr.2013.12.010"xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Lee D."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Lee D."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Lee J."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Lee J."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Kataoka H."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Kataoka H."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Nishikawa S."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Nishikawa S."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Yang H."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Yang H."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Kim C."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Kim C."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Park J.S."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Park J.S."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Jung J."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Jung J."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Park I."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Park I."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Kim I."xsd:string
http://purl.uniprot.org/citations/24434213http://purl.uniprot.org/core/author"Kim I."xsd:string